Phase
Condition
Breast Cancer
Cancer
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male or female aged ≥ 18 years
Patient diagnosed with HER2-negative eBC
Patient about to be initiated with adjuvant Olaparib at their physician's discretion
Patient has been informed and does not object to participation in the study.
Exclusion
Exclusion Criteria:
Patient not consenting to participate.
Patients included in the Early Access Program
Study Design
Study Description
Connect with a study center
Research Site
Beauvais Cedex,
FranceSite Not Available
Research Site
Caen,
FranceSite Not Available
Research Site
Chambray Les Tours,
FranceActive - Recruiting
Research Site
Dechy,
FranceSite Not Available
Research Site
Frejus Cedex,
FranceSite Not Available
Research Site
Grenoble,
FranceSite Not Available
Research Site
Le Blanc Mesnil,
FranceSite Not Available
Research Site
Lille Cedex,
FranceSite Not Available
Research Site
Limoges Cedex 1,
FranceSite Not Available
Research Site
Metz Tessy,
FranceSite Not Available
Research Site
Montpellier,
FranceSite Not Available
Research Site
Nice Cedex 2,
FranceSite Not Available
Research Site
Poitiers Cedex,
FranceSite Not Available
Research Site
Rouen Cedex,
FranceActive - Recruiting
Research Site
St Gregoire Cedex,
FranceSite Not Available
Research Site
St Martin Boulogne,
FranceSite Not Available
Research Site
St Pierre Cedex,
FranceSite Not Available
Research Site
Thonon les bains,
FranceSite Not Available
Research Site
Valence Cedex 9,
FranceSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.